These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10699024)

  • 21. [Comparison of the CMV antigenemia test and CMV-DNA PCR results in solid organ transplant recipients].
    Özkarata E; Özbek ÖA; Avkan Oğuz V; Sayıner AA
    Mikrobiyol Bul; 2016 Jan; 50(1):44-52. PubMed ID: 27058328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two molecular assays for detection of cytomegalovirus DNA in whole blood and plasma samples from transplant recipients.
    Costa C; Sidoti F; Mantovani S; Gregori G; Proietti A; Ghisetti V; Cavallo R
    New Microbiol; 2016 Jul; 39(3):186-191. PubMed ID: 27284983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus quantification in plasma with Abbott RealTime CMV and Roche Cobas Amplicor CMV assays.
    Tremblay MA; Rodrigue MA; Deschênes L; Boivin G; Longtin J
    J Virol Methods; 2015 Dec; 225():1-3. PubMed ID: 26341060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the AMPLICOR CMV, COBAS AMPLICOR CMV monitor and antigenemia assay for cytomegalovirus disease.
    Masaoka T; Hiraoka A; Ohta K; Tatsumi N; Watanabe S; Hotta T; Yabe H; Kato S; Aikawa A; Ohara T; Hasegawa A; Tanabe K; Toma H; Yasuoka A; Oka S
    Jpn J Infect Dis; 2001 Feb; 54(1):12-6. PubMed ID: 11326123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems.
    Razonable RR; Brown RA; Espy MJ; Rivero A; Kremers W; Wilson J; Groettum C; Smith TF; Paya CV
    J Clin Microbiol; 2001 Dec; 39(12):4472-6. PubMed ID: 11724864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
    Solano C; Muñoz I; Gutiérrez A; Farga A; Prósper F; García-Conde J; Navarro D; Gimeno C
    J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the Murex Hybrid Capture CMV DNA (v2.0) assay and the pp65 CMV antigenemia test for the detection and quantitation of CMV in blood samples from immunocompromised patients.
    Schirm J; Kooistra A; van Son WJ; van der Bij W; Verschuuren E; Sprenger HG; Limburg PC; The TH
    J Clin Virol; 1999 Dec; 14(3):153-65. PubMed ID: 10614852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CMV viral load measurements in whole blood and plasma--which is best following renal transplantation?
    Barrett-Muir W; Breuer J; Millar C; Thomas J; Jeffries D; Yaqoob M; Aitken C
    Transplantation; 2000 Jul; 70(1):116-9. PubMed ID: 10919585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
    Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
    Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development of a beacon-based real-time PCR for cytomegalovirus and its application in immunocompromised patients.
    Tung YC; Ke LY; Tsai WC; Lin KH; Tsai SM; Wang CF; Lee HF; Su HJ; Lu PL
    Clin Lab; 2014; 60(11):1895-901. PubMed ID: 25648032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of a duplex quantitative real-time PCR assay and the COBAS Amplicor CMV Monitor test for detection of cytomegalovirus.
    Herrmann B; Larsson VC; Rubin CJ; Sund F; Eriksson BM; Arvidson J; Yun Z; Bondeson K; Blomberg J
    J Clin Microbiol; 2004 May; 42(5):1909-14. PubMed ID: 15131148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of cytomegalovirus in plasma and cerebrospinal fluid specimens from human immunodeficiency virus-infected patients by the AMPLICOR CMV test.
    Long CM; Drew L; Miner R; Jekic-McMullen D; Impraim C; Kao SY
    J Clin Microbiol; 1998 Sep; 36(9):2434-8. PubMed ID: 9705369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.
    Piiparinen H; Helanterä I; Lappalainen M; Suni J; Koskinen P; Grönhagen-Riska C; Lautenschlager I
    J Med Virol; 2005 Jul; 76(3):367-72. PubMed ID: 15902704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of laboratory assays to predict cytomegalovirus disease in renal transplant recipients.
    Tong CY; Cuevas L; Williams H; Bakran A
    J Clin Microbiol; 1998 Sep; 36(9):2681-5. PubMed ID: 9705413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation.
    Boivin G; Bélanger R; Delage R; Béliveau C; Demers C; Goyette N; Roy J
    J Clin Microbiol; 2000 Dec; 38(12):4356-60. PubMed ID: 11101564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipients.
    Garrigue I; Doussau A; Asselineau J; Bricout H; Couzi L; Rio C; Merville P; Fleury H; Lafon ME; Thiébaut R
    J Clin Microbiol; 2008 Feb; 46(2):493-8. PubMed ID: 18057128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole blood real-time quantitative PCR for cytomegalovirus infection follow-up in transplant recipients.
    Garrigue I; Boucher S; Couzi L; Caumont A; Dromer C; Neau-Cransac M; Tabrizi R; Schrive MH; Fleury H; Lafon ME
    J Clin Virol; 2006 May; 36(1):72-5. PubMed ID: 16481215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of quantitative methods of DNA CMV investigation in clinical samples obtained from symptomatic and asymptomatic patients undergo renal transplantation].
    Siennicka J
    Med Dosw Mikrobiol; 2008; 60(2):155-61. PubMed ID: 18819451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus quantification in plasma by an automated real-time PCR assay.
    Yerly S; Perrin L; Van Delden C; Schaffer S; Thamm S; Wunderli W; Kaiser L
    J Clin Virol; 2007 Apr; 38(4):298-303. PubMed ID: 17321200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of low cytomegalovirus DNA levels in human plasma.
    Waggoner J; Ho DY; Libiran P; Pinsky BA
    J Clin Microbiol; 2012 Jul; 50(7):2378-83. PubMed ID: 22518866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.